Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12559765rdf:typepubmed:Citationlld:pubmed
pubmed-article:12559765lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C0682969lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C0017710lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C0034809lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C0010423lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C0597358lld:lifeskim
pubmed-article:12559765lifeskim:mentionsumls-concept:C1261552lld:lifeskim
pubmed-article:12559765pubmed:issue2lld:pubmed
pubmed-article:12559765pubmed:dateCreated2003-1-31lld:pubmed
pubmed-article:12559765pubmed:abstractTextThe crystal structure of the glucocorticoid receptor (GR) ligand binding domain in a ternary complex with dexamethasone and a TIF2 coactivator peptide has been determined recently. The structure reveals several distinct features not found in other nuclear receptors, such as a novel dimerization interface and a second charge clamp that might be important in determining coactivator binding selectivity. The GR ligand binding domain also has a steroid binding pocket that is distinct from other nuclear receptors and might explain its selectivity for glucocorticoids and its diversity of responses.lld:pubmed
pubmed-article:12559765pubmed:languageenglld:pubmed
pubmed-article:12559765pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12559765pubmed:citationSubsetIMlld:pubmed
pubmed-article:12559765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12559765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12559765pubmed:statusMEDLINElld:pubmed
pubmed-article:12559765pubmed:monthFeblld:pubmed
pubmed-article:12559765pubmed:issn0165-6147lld:pubmed
pubmed-article:12559765pubmed:authorpubmed-author:CidlowskiJohn...lld:pubmed
pubmed-article:12559765pubmed:authorpubmed-author:NecelaBrian...lld:pubmed
pubmed-article:12559765pubmed:issnTypePrintlld:pubmed
pubmed-article:12559765pubmed:volume24lld:pubmed
pubmed-article:12559765pubmed:ownerNLMlld:pubmed
pubmed-article:12559765pubmed:authorsCompleteYlld:pubmed
pubmed-article:12559765pubmed:pagination58-61lld:pubmed
pubmed-article:12559765pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:meshHeadingpubmed-meshheading:12559765...lld:pubmed
pubmed-article:12559765pubmed:year2003lld:pubmed
pubmed-article:12559765pubmed:articleTitleCrystallization of the human glucocorticoid receptor ligand binding domain: a step towards selective glucocorticoids.lld:pubmed
pubmed-article:12559765pubmed:affiliationLaboratory of Signal Transduction, Building 101, MD F3-07, Department of Health and Human Services, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.lld:pubmed
pubmed-article:12559765pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12559765pubmed:publicationTypeReviewlld:pubmed